Amy Hough

Amy Hough

Auto-generated profile, based on publicly available information

Amy Hough

Sexual Health Services, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2020 in International Journal of Palliative Nursing
Verified
Journal Article
Closed access
AHAmy Hough
Amy Hough
GDGeorgia Daisy Dell
Georgia Daisy Dell
MBMichael Blaber
Michael Blaber
DKDiana Kavanagh
Diana Kavanagh
ALAnna Lock
Anna Lock
This narrative describes the experiences of an inner city respiratory unit that was transformed to treat COVID-19 patients with continuous positive airway pressure (CPAP) ventilation who were not scheduled for any further escalation in treatment. The high mortality rate and unconventional way of dying led to the creation of local guidance for removing assisted ventilation when the treatment ceased to be effective. We reflect on the specific challenges that caring for these patients holistically has presented and how we have learnt to deliver good palliative care in a unique set of circumstances. We also consider the impact of the pandemic on our team and how the development of a multidisciplinary support system has improved team dynamics and ultimately patient care.

8 August 2024 in BMJ Sexual & Reproductive Health
Verified
Journal Article
Closed access
PDF file
AHAmy Hough
Amy Hough
JKJayne Kavanagh
Jayne Kavanagh
NPNeha Pathak
Neha Pathak
Before starting the implant removal, the HCP discusses pregnancy planning with Sofia. They advise her to consult her general practitioner (GP) to start 5 mg/day folic acid (table 1), have a cervical screening test and be tested for diabetes. The HCP sensitively brings up Sofia’s weight and alcohol intake. They explain that she could reduce her risk of complications during pregnancy and delivery by aiming for 5–10% weight loss and signposts her to the National Health Service (NHS) ‘Live Well’ website. The HCP also discusses the benefits of not drinking alcohol before and during the pregnancy, and encourages her to discuss these lifestyle changes with her partner as well, as men can …

14 September 2024 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
AHAmy Hough
Amy Hough
JZJavier Zamora
Javier Zamora
STShakila Thangaratinam
Shakila Thangaratinam
JAJohn Allotey
John Allotey

9 July 2025 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
CSCatherine Stewart
Catherine Stewart
AHAmy Hough
Amy Hough
MPMelissa Palmer
Melissa Palmer
OMOna McCarthy
Ona McCarthy
RFRebecca S. French
Rebecca S. French
NPNeha Pathak
Neha Pathak
Objective: This study investigates contraceptive use among individuals who have recently given birth. It aims to identify factors associated with contraceptive use at two months and one‐year of giving birth. Additionally, it assesses whether receiving and being satisfied with contraceptive counselling influences contraceptive use. Design: Cross‐sectional analysis of data from the 2023 Women's Reproductive Health Survey. Setting: England. Population: Participants who had given birth in the last year ( n = 2044). Methods: Bivariate and multivariable logistic regressions examined factors associated with contraceptive use. Main Outcome Measures: Contraceptive initiation within two months of giving birth. Contraceptive use within one year of giving birth. Results: Overall, 73% ( n = 1489/2044) of participants were using contraception, however 58% ( n = 1154/1998) had not initiated use within two months of giving birth. Bivariate analyses indicated that younger participants, those who received counselling, and those satisfied with it had higher odds of initiating contraception within two months. Similarly, younger individuals, those not desiring more children, and those who received counselling had higher odds of using contraception within one year. Multivariable analysis showed that receiving counselling and being satisfied with it were significantly associated with early initiation. Conclusions: This study highlights the need for high‐quality contraceptive counselling as part of maternity care. Counselling during or immediately after pregnancy was shown to impact contraceptive initiation and use. Policy improvements and further research on achieving universal high‐quality counselling are important to ensure equitable access to contraception.

6 August 2026 in medRxiv
Verified
Preprint
Open access
HBH Brotherton
H Brotherton
AGA Gai
A Gai
GWG Walker
G Walker
YNY Njie
Y Njie
SKS Kapoor
S Kapoor
JLJe Lawn
Je Lawn
Background: Trial participation effect, defined as a change in clinical outcomes associated with trial enrolment regardless of allocation, is understudied in neonatal trials in low- and middle-income countries (LMICs), despite its importance for trial design, interpretation, and research ethics. This study aimed to quantify the trial participation effect and explore potential ways by which research participation may influence neonatal survival. Methods: This observational cohort study included neonates weighing <2Kg and aged <24h who were admitted to a Gambian referral hospital and either enrolled in a clinical trial comparing early versus later KMC (eKMC trial;2018-2020) or not enrolled due to operational constraints and hence received standard, non-research care. All infants were prospectively followed until in-patient discharge or death. The eKMC trial previously found no important effect of early KMC on all-cause neonatal mortality. For this analysis, in-patient mortality rates were compared using a generalised linear model, adjusting for baseline differences in participant characteristics. Prospectively collected data on small and sick newborn care readiness and delivery during the trial period were used to explore how trial participation may have influenced survival. Results: A total of 545 neonates were included: 279 enrolled in the trial and 266 not enrolled, predominantly due to the absence of an available caregiver. Baseline characteristics were similar between groups, although differences were seen in twin status, place of birth, and age at admission. Trial participation was associated with an absolute reduction in inpatient mortality of 6.3% (22.6% (63/279) among enrolled versus 28.9% (77/266) among non-enrolled) and a relative reduction of 29% (aRR 0.71, 95% CI 0.53–0.96). This association varied by season, with no evidence of benefit during the dry season (aRR 0.97, 95% CI 0.60-1.58), but a 40% reduction in adjusted mortality risk during the rainy season (aRR 0.60, 95% CI 0.41-0.87)(Interaction test: p =0.086). Trial participants had access to laboratory diagnostics and received more intensive clinical monitoring, including higher staffing ratios, continuous pulse oximetry, structured education of carers on neonatal danger signs, and enhanced scrutiny of clinical management compared to neonates receiving routine care. Conclusion: Trial participation was associated with a substantial reduction in inpatient mortality, suggesting that participation effects should be considered when designing, interpreting, and reporting neonatal clinical trials in LMIC settings. The association was evident only during the rainy season. The participation effect may have been mediated by increased clinical oversight and monitoring, additional nursing support, and access to diagnostic investigations, all of which should be prioritised within routine care to accelerate progress towards SDG neonatal survival targets. Key messages: What is already known on this topic - It is widely perceived that patients in low- and middle-income countries (LMICs) may benefit from participation in clinical trials because of additional resources and access to otherwise-unavailable health services. - The magnitude of the trial participation effect on neonatal survival in LMICs has not previously been quantified What this study adds - This is the first study from an LMIC to quantify an association between participation in an individually randomised neonatal clinical trial and reduced inpatient mortality. - Preterm/low birth weight (LBW) newborns enrolled in the eKMC trial had 29% lower adjusted relative risk of inpatient mortality compared to clinically comparable, non-enrolled infants receiving routine care at the same neonatal unit - The association between trial participation and reduced mortality was observed only during the rainy season (July-October), when mortality rates were highest, suggesting that participation effects may be most important in higher-mortality contexts. - Trial participants received enhanced clinical monitoring and higher-quality small and sick newborn care (SSNC), including continuous pulse oximetry, higher nursing availability, rigorous safety oversight, and access to laboratory diagnostics, especially blood cultures. These findings demonstrate that preterm/LBW newborns can safely participate in clinical trials in resource-limited settings when essential components of SSNC are in place. - The study identified key elements of SSNC that should be prioritised within health-system strengthening efforts to accelerate progress towards SDG 3.2. How this study might affect research, practice or policy - Research: These findings provide the first quantifiable estimate of a neonatal trial participation effect in a low-resource, high-mortality hospital setting. This information could improve the accuracy of sample size calculations and interpretation of trial findings, reducing the risk of underpowered studies and research inefficiency. The findings also highlight the ethical importance of measuring and reporting trial participation effects, particularly in settings where research activities may strengthen the quality of routine newborn care and where effects may be greatest during periods of high mortality risk. - Clinical practice: Key components of SSNC that differed between trial participants and non-participants, included continuous monitoring, higher nursing availability, regular safety oversight, and access to microbiological diagnostics. Strengthening these elements within routine care could improve outcomes for preterm/LBW neonates regardless of research participation and especially in highest mortality settings. - Policy: Investments in neonatal monitoring capacity, nursing, safety and clinical governance, and microbiology services should be prioritised within national newborn health strategies to accelerate progress towards SDG3.2. The greater impact observed during the high-mortality rainy season suggests that such investments may yield the largest survival gains in the highest burden, vulnerable global contexts.

15 January 2025 in BMJ Sexual & Reproductive Health
Verified
Journal Article
Closed access
AHAmy Hough
Amy Hough
JKJayne Kavanagh
Jayne Kavanagh
NPNeha Pathak
Neha Pathak